新基制药(CELG)

主要力量2016-06-22 00:13

$双鹭药业(SZ002038)$ $新基制药(CELG)$ 新基大跌，和双鹭有关吗？查看全文

uclaxz2016-06-21 21:43

$新基制药(CELG)$ 垃圾时间太长查看全文

The-Terminator2016-06-01 10:18

$双鹭药业(SZ002038)$受$CELATOR PHARMACEUTICALS INC(CPXX)$大涨的影响？双鹭要是在美股估计早被$新基(CELG)$邀约收购了～查看全文

资本主义拉美行不通2016-05-20 13:23

OMG，脸都被打肿了$新基(CELG)$查看全文

tiger-in-motion2016-04-04 03:05

回复@范小饭9896: XBI 和IBB 最大的区别是 持仓权重不同，IBB 中GILD, BIIB, CELG, AMGN 占比接近4成，XBI 更分散//@范小饭9896:回复@TigerinMotion:虎哥，买XBI的call是否可行？查看全文

疯狂期权FO2016-03-25 02:45

手上的看空头寸差不多全部出清. 主力头寸剩下$新基(CELG)$ put debit spread, $债券20+美公债指数ETF-iShares Barcla(TLT)$ call, $PayPal(PYPL)$ call/put credit spread.查看全文

疯狂期权FO2016-03-22 14:04

目前手上持有 $标普500指数ETF-SPDR(SPY)$ put; $债券20+美公债指数ETF-iShares Barcla(TLT)$ call; $苹果(AAPL)$ call credit spread; $摩根大通(JPM)$ put; $新基(CELG)$ put. 准备等信号做空$罗素2000指数ETF-iShares (IWM)$, 这堆垃圾已经跑得够高了.查看全文

为何抄底VRX 可能是一个危险的自毁行为

tiger-in-motion2016-03-19 23:23

$凡利亚药品国际(VRX)$
1， 观察VRX 的最近的下跌中一个有意思的现象是 借股的成本并不高，IB 的费率只有0.48%，说明有足够的股票可供借出卖出，股价在被拦腰一半后 还能下跌20% 并非是蜂拥而至的做空者造成的。
2. BILL ACKMAN 还深陷其中，并未认错出局。 BILL ACKMAN 的PERSHING SQUARE...查看全文

十分之九2016-03-09 15:31

$新基(CELG)$ 可以考虑建仓了，Ibb，xbi。查看全文

坐以待币2016-02-08 23:16

$新基(CELG)$ 真正的成长股，穿越牛熊查看全文

$新基制药(CELG)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-013792  Size: 69 KB 网页链接

$新基制药(CELG)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-013796  Size: 42 KB 网页链接

$新基制药(CELG)$ 15-12B Securities registration termination [Section 12(b)] Accession Number: 0001140361-19-022527  Act: 34  Size: 15 KB 网页链接

$新基制药(CELG)$ S-4 POS Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments Accession Number: 0001140361-19-022225  Act: 33  Size: 20 KB 网页链接

$新基制药(CELG)$ S-4 POS Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments Accession Number: 0001140361-19-022228  Act: 33  Size: 20 KB 网页链接

$新基制药(CELG)$ S-4 POS Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments Accession Number: 0001140361-19-022200  Act: 33  Size: 20 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022201  Act: 33  Size: 39 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022206  Act: 33  Size: 39 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022210  Act: 33  Size: 39 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022217  Act: 33  Size: 39 KB 网页链接